Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary
Abstract Narcolepsy is associated with disrupted nighttime sleep (DNS). Sodium oxybate (SXB; Xyrem®), administered twice nightly, is indicated for the treatment of cataplexy and excessive daytime sleepiness in patients 7 years or older with narcolepsy. Recently, low-sodium oxybate (LXB, Xywav®; for...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Adis, Springer Healthcare
2023-09-01
|
| Серія: | Neurology and Therapy |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1007/s40120-023-00543-z |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
